Package 72559-038-23

{"route": ["ORAL"], "spl_id": "39334fb3-e395-7819-e063-6294a90a9073", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["199047"], "spl_set_id": ["33dc93a5-ee03-2e68-e063-6294a90aeee1"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Little Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "300 mg in 1 BOTTLE (72559-038-23)", "package_ndc": "72559-038-23", "marketing_start_date": "20250515"}], "brand_name": "Famotidine", "product_id": "72559-038_39334fb3-e395-7819-e063-6294a90a9073", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "72559-038", "generic_name": "Famotidine", "labeler_name": "Little Pharma, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/10mg"}], "application_number": "ANDA215766", "marketing_category": "ANDA", "marketing_start_date": "20250515", "listing_expiration_date": "20261231"}